Future Microbiology

• Regulation of Angiogenesis in Malignancies Associated With Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpes Virus New treatment modalities that target members of the VEGF family have gained approval for clinical use in cancer.
  Future Microbiology, November 2009
• Molecular Targets for Antiviral Therapy of Cytomegalovirus Infections There remains a need for new potent and safe antiviral drugs for CMV infections. This review focuses on target molecules involved in the development of novel antiviral drugs for CMV.
  Future Microbiology, October 2009
• Genetics of Antimicrobial Resistance in Staphylococcus Aureus New ways to combat resistant strains of Staphylococcus aureus are likely to come from genomics, proteomics, and other modern research areas.
  Future Microbiology, October 2009
• Human Lyme Disease Vaccines: Past and Future Concerns The pursuit of a human vaccine for Lyme disease, the most common arthropod-borne infection in the US, is an important and worthwhile endeavor, according to this review of the topic.
  Future Microbiology, October 2009
• Helicobacter Pylori: Phenotypes, Genotypes and Virulence Genes Helicobacter Pylori is a bacterium frequently found in the mucus layer of the stomach. This review discusses the role of phenotypes and genotypes of Helicobacter Pylori on gastric colonization.
  Future Microbiology, March 2009
• ce of CandidThe Enigma of the Major Repeat Sequena Albicans Major Repeat Sequence (MRS) refers to a stretch of complex DNA found in at least 9 copies of the Candida albicans genome. Find out the latest evidence for its role in chromosome dynamics.
  Future Microbiology, March 2009
• Recent Discoveries in the Pathogenesis and Immune Response Toward Entamoeba histolytica Entamoeba histolytica is a protozoan parasite that causes amoebiasis. Recent studies have revealed opportunities to produce an effective vaccine against the Entamoeba histolytica infection.
  Future Microbiology, February 2009
• Anti-toxin Antibodies in Prophylaxis and Treatment of Inhalation Anthrax Learn more about existing and recent developments in anti-toxin antibodies designed to protect against inhaled anthrax.
  Future Microbiology, February 2009
• Chronic Lyme Disease and the "Axis of Evil" Lyme disease is a controversial clinical conundrum. Over the past decade, two opposing views have emerged, one from the Infectious Diseases Society of America (IDSA) and the other represented by the International Lyme and Associated Diseases Society (ILADS).
  Future Microbiology, December 2008
• Drug Treatment for Multidrug-resistant Acinetobacter baumannii Infections Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections. Here's what you need to know to prevent these infections.
  Future Microbiology, December 2008
• Acquired Vancomycin Resistance in Clinically Relevant Pathogens Read this review and update on acquired vancomycin resistance.
  Future Microbiology, October 2008
• Resistance Issues in Treating Chronic Hepatitis B Read this review and update on how to treat drug-resistant hepatitis B.
  Future Microbiology, October 2008
• Staphylococcus aureus Evasion of Innate Antimicrobial Defense Lessons from recent studies on antimicrobial host defense molecules and cognate bacterial resistance adaptation should help in the development of more sustainable anti-infective compounds.
  Future Microbiology, August 2008
• Candidemia in the 21st Century Read about the changing epidemiology of candidal bloodstream infections, its impact on healthcare and new advances in the diagnosis and treatment of candidemia.
  Future Microbiology, August 2008
• Getting to the Heart of the Problem: Serological and Molecular Techniques in the Diagnosis of Infective Endocarditis The authors discuss techniques that will become increasingly important not only in the routine investigation of infectious disease, but specifically the diagnosis of endocarditis.
  Future Microbiology, June 2008
• Using Innate Immunity to Characterize the Host Response to Microbial Invasion in Severe Sepsis Despite considerable progress, clinical application of these approaches to pathogen recognition in hospitalized patients with severe sepsis is still years away.
  Future Microbiology, April 2008
• Scabies: Molecular Perspectives and Therapeutic Implications in the Face of Emerging Drug Resistance Recent advances are providing new insights into scabies mite biology and genetic mechanisms underlying drug resistance.
  Future Microbiology, February 2008
• Use of Animal Models in the Development of Human Vaccines Efficient translation of basic vaccine research to clinical therapies will depend upon the availability of appropriate animal models.
  Future Microbiology, December 2007
• The US National Antimicrobial Resistance Monitoring System NARMS surveillance and research activities are designed to minimize public health concerns with regards to antimicrobial use in food animals.
  Future Microbiology, October 2007
• Whac-a-mole: Future Trends in Chagas Transmission and the Importance of a Global Perspective on Disease Control Like in the arcade game, the Chagas "mole" will continue to pop up in nonendemic countries, so healthcare workers must be prepared to strike.
  Future Microbiology, August 2007